Discover Codiak BioSciences’ groundbreaking patent on engineered extracellular vesicles (EVs) for targeted disease treatment, including cancer and infections.
Eisai heads to FDA with subcutaneous version of Alzheimer’s treatment developed with Biogen
Eisai and Biogen said Tuesday that they started an application for an under-the-skin maintenance dosing version of their Alzheimer’s treatment Leqembi. The subcutaneous submission was